These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26755879)

  • 21. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
    Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
    Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
    Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.
    Hallenbeck PL; Chang YN; Hay C; Golightly D; Stewart D; Lin J; Phipps S; Chiang YL
    Hum Gene Ther; 1999 Jul; 10(10):1721-33. PubMed ID: 10428217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological landscape and immunotherapy of hepatocellular carcinoma.
    Prieto J; Melero I; Sangro B
    Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):681-700. PubMed ID: 26484443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in experimental and translational research in the treatment of hepatocellular carcinoma.
    Kidner T; Dai M; Adusumilli PS; Fong Y
    Surg Oncol Clin N Am; 2008 Apr; 17(2):377-89, ix. PubMed ID: 18375358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.
    Ding B; Li T; Zhang J; Zhao L; Zhai G
    Curr Gene Ther; 2012 Apr; 12(2):92-102. PubMed ID: 22348553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current treatment in advanced hepatocellular carcinoma and prospects for immuno-oncology therapy].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):561-565. PubMed ID: 28835076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
    Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
    Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer gene therapy using adeno-associated virus vectors.
    Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH
    Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
    Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
    Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
    Harding JJ; El Dika I; Abou-Alfa GK
    Cancer; 2016 Feb; 122(3):367-77. PubMed ID: 26540029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
    Burova E; Ioffe E
    Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in delivery vectors for gene therapy in liver cancer.
    Redd Bowman KE; Lu P; Vander Mause ER; Lim CS
    Ther Deliv; 2020 Jan; 11(1):833-850. PubMed ID: 31840560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?
    van der Laan LJ; Wang Y; Tilanus HW; Janssen HL; Pan Q
    Expert Opin Biol Ther; 2011 Mar; 11(3):315-27. PubMed ID: 21204741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiality of immunotherapy against hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy of liver cancer.
    Hernandez-Alcoceba R; Sangro B; Prieto J
    World J Gastroenterol; 2006 Oct; 12(38):6085-97. PubMed ID: 17036377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.